August 01, 2014 8:03 PM ET

Diversified Consumer Services

Company Overview of McMaster University

Company Overview

McMaster University is headquartered in Hamilton, Canada.

1280 Main Street West

Hamilton, ON L8S4L8

Canada

Phone:

905-525-9140

Fax:

905-540-8443

Key Executives for McMaster University

President
Director of School for Engineering Practice
Dean of Engineering
Adjunct Professor - Michael G. DeGroote School of Business
Vice President of Research & International Affairs
Compensation as of Fiscal Year 2014.

McMaster University Key Developments

Mcmaster University and Cisco Collaborate to Further Bioinformatics Research and Build Institutional Research Cloud

McMaster University and Cisco Systems Canada Co. announced they have established a long-term relationship which will see the university increase research activities in Integrated Health Biosystems and Bioinformatics. McMaster and Cisco will also establish a university-wide research cloud computing environment and infrastructure. This partnership will see McMaster build on its renowned research successes and strengthen its links with national and international partners from academia, government and industry. As part of the agreement, Cisco is providing a $2.1 million contribution to McMaster. The contribution includes $1.6 million over eight years to establish a Professorship in Integrated Health Biosystems, as well as $500,000 over five years to establish a Research Chair in Bioinformatics. The Research Chair in Bioinformatics will collaborate on a program in Integrated Health Biosystems, the aim of which will be to bridge the existing gulf between data-intensive areas of biomedical research and healthcare by integrating diverse biological datasets with clinical and environmental data.

Genoa Pharmaceuticals, Inc. and McMaster University to Collaborate on Idiopathic Pulmonary Fibrosis Research

Genoa Pharmaceuticals, Inc. announced it is collaborating with Dr. Martin Kolb and researchers at McMaster University to characterize the in vivo advantages and potential clinical impact of Genoa's lead program, inhaled GP-101 (aerosol pirfenidone) for the treatment of IPF. The research will combine Genoa's expertise in aerosol drug delivery with McMaster's expertise in exploring mechanisms of pulmonary fibrosis and managing patients with IPF.

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact McMaster University, please visit www.mcmaster.ca. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.